Show simple item record

dc.contributor.authorNiu, X
dc.contributor.authorPerdomo, S
dc.contributor.authorBlackhall, Fiona H
dc.date.accessioned2017-08-22T16:19:32Z
dc.date.available2017-08-22T16:19:32Z
dc.date.issued2017-03
dc.identifier.citationMolecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients. 2017, 6 (S2):S239-245 Translational Cancer Researchen
dc.identifier.issn2218676X
dc.identifier.issn22196803
dc.identifier.doi10.21037/tcr.2017.03.22
dc.identifier.urihttp://hdl.handle.net/10541/620516
dc.language.isoenen
dc.relation.urlhttp://tcr.amegroups.com/article/view/12809/10721en
dc.rightsArchived with thanks to Translational Cancer Researchen
dc.titleMolecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients.en
dc.typeArticleen
dc.contributor.departmentDepartment of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghaien
dc.identifier.journalTranslational Cancer Researchen
refterms.dateFOA2018-12-17T15:03:00Z


Files in this item

Thumbnail
Name:
tcr-06-S2-S239.pdf
Size:
420.5Kb
Format:
PDF
Description:
Full text, Open Access article

This item appears in the following Collection(s)

Show simple item record